4-Fluoroethylphenidate
Appearance
Identifiers | |
---|---|
| |
CAS Number | |
PubChem CID | |
CompTox Dashboard (EPA) | |
Chemical and physical data | |
Formula | C15H20FNO2 |
Molar mass | 265.328 g·mol−1 |
3D model (JSmol) | |
| |
|
4-Fluoroethylphenidate (4F-EPH) is a recreational designer drug from the phenidate family, with stimulant effects. It was first identified in France in March 2016.[1] It has been used as a nootropic drug,[2] and was made illegal in the UK in 2017,[3] and in Sweden in 2018.[4]
See also
[edit]References
[edit]- ^ "EMCDDA–Europol 2016 Annual Report on the implementation of Council Decision 2005/387/JHA" (PDF). Europol & European Monitoring Centre for Drugs and Drug Addiction (EMCDDA).
- ^ Zaami S, Tagliabracci A, Berretta P, Busardò FP, Marinelli E (2019). "Use of Methylphenidate Analogues as Cognitive Enhancers: The Prelude to Cosmetic Neurology and an Ethical Issue". Frontiers in Psychiatry. 10: 1006. doi:10.3389/fpsyt.2019.01006. PMC 6989549. PMID 32038333.
- ^ "The Misuse of Drugs Act 1971 (Amendment) Order 2017" (PDF). Government of the United Kingdom. 2017.
- ^ "Ordinance amending the Ordinance (1999:58) banning certain products that are harmful to health. Notification Number: 2021/241/S". Swedish Code of Statutes.